Skip to main content
SpringerLink
Log in

Pilocarpine adds to the range of treatment options in xerostomia

  • New Drugs and Therapeutics
  • Published:
Drugs & Therapy Perspectives Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. News from the FDA. Inpharma 1994 Apr 4; (932): 22

  2. Salagen tablets. Pharm J 1995 Mar 11; 254: 335

    Google Scholar 

  3. Sreebny LM, Valdini A. Xerostomia: a neglected symptom. Arch Intern Med 1987; 147: 1333–7

    Article  PubMed  CAS  Google Scholar 

  4. Greenspan D. Management of salivary dysfunction. NCI Monogr 1990; 9: 159–61

    PubMed  Google Scholar 

  5. Valdez IH, Atkinson JC, Ship JA, et al. Major salivary gland function in patients with radiation-induced xerostomia: flow rates and sialochemistry. Int J Radiation Oncology 1993; 25: 41–7

    Article  CAS  Google Scholar 

  6. Oxholm P, Prause JU, Schiødt M. Pathogenesis and management of primary Sjögren’s syndrome. Clin Immunother 1994; 2: 421–29

    Article  Google Scholar 

  7. Navazesh M, Ship II. Xerostomia: diagnosis and treatment. Am J Otolaryngol 1983; 4: 283–92

    Article  PubMed  CAS  Google Scholar 

  8. Wiesenfeld D, Stewart AM. A critical assessment of oral lubricants in patients with xerostomia. Br Dent J 1983; 155: 155–7

    Article  PubMed  CAS  Google Scholar 

  9. Duxbury AJ, Thakker NS, Wastell DG. A double-blind cross-over trial of a mucin-containing artificial saliva. Br Dent J 1989; 166: 115–20

    Article  PubMed  CAS  Google Scholar 

  10. Fox PC. Systemic therapy of salivary gland hypofunction. J Dent Res 1987; 66(Special Issue): 689–92

    PubMed  Google Scholar 

  11. Wiseman LR, Faulds D. Oral pilocarpine: a review of its pharmacological properties and clinical potential in xerostomia. Drugs 1995; 49: 143–55

    Article  PubMed  CAS  Google Scholar 

  12. Fox PC, Atkinson JC, Macynski AA, et al. Pilocarpine treatment of salivary gland hypofunction and dry mouth (xerostomia). Arch Intern Med 1991; 151: 1149–52

    Article  PubMed  CAS  Google Scholar 

  13. LeVeque FG, Montgomery M, Potter D, et al. A multicenter, randomized, double-blind, placebo-controlled, dose titration study of oral pilocarpine for treatment of radiation-induced xerostomia in head and neck cancer patients. J Clin Oncol 1993; 11: 1124–31

    PubMed  CAS  Google Scholar 

  14. Johnson JT, Ferretti GA, Nethery WJ, et al. Oral pilocarpine for post-irradiation xerostomia in patients with head and neck cancer. N Engl J Med 1993; 329: 390–5

    Article  PubMed  CAS  Google Scholar 

  15. Valdez IH, Wolff A, Atkinson JC, et al. Use of pilocarpine during head and neck radiation therapy to reduce xerostomia and salivary dysfunction. Cancer 1993; 71: 1848–51

    Article  PubMed  CAS  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pilocarpine adds to the range of treatment options in xerostomia. Drugs Ther. Perspect 5, 5–7 (1995). https://doi.org/10.2165/00042310-199505080-00002

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00042310-199505080-00002

Keywords

Search

Navigation